{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:03:25Z","timestamp":1792206205177,"version":"4.4.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Justification<\/jats:title><jats:p>We have previously documented that in individuals with chronic rhinosinusitis (CRS) refractory to surgery, intranasal application of live <jats:italic>Lactococcus lactis W136<\/jats:italic>, a probiotic bacterium, improves sinus-specific symptoms, SNOT-22, and mucosal aspect on endoscopy, accompanied by a reduction in sinus pathogens and an increase in protective bacteria. The present work explores the molecular mechanisms underpinning these observations using transcriptomics of the sinus mucosa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Epithelial brushings collected prospectively as a sub-study of the <jats:italic>L. lactis W136<\/jats:italic> clinical trial were used to probe epithelial responses to microbiome supplementation using a hypothesis-free bioinformatic analysis of gene expression analysis. Samples from twenty-four patients with CRS refractory to medical and surgical management were prospectively collected during a clinical trial assessing the effect of 14 days of BID nasal irrigation with 1.2 billion CFU of live <jats:italic>L. lactis W136<\/jats:italic> probiotic bacteria (CRSwNP\u2009=\u200917, CRSsNP\u2009=\u20097). Endoscopically guided sinus brushings were collected as part of the initial study, with brushings performed immediately before and after treatment. Following RNA extraction, samples were assessed using the Illumina HumanHT-12 V4 BeadChip. Differential gene expression was calculated, and pathway enrichment analysis was performed to identify potentially implicated processes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Differentially identified transcripts and pathways were assessed for the overall population and the clinical phenotypes of CRSwNP and CRSsNP. Patterns of response to treatment were similar across all groups, implicating pathways for the regulation of immunity and epithelial cell regulation. These resemble the patterns of improvement observed following successful treatment with endoscopic sinus surgery or azithromycin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Gene expression profiling following the application of live bacteria to the diseased sinus epithelium highlights the implication of multiple components of the inflammation-microbiome-epithelial barrier axis implicated in CRS. These effects appear to involve both epithelial restoration and modulation of innate and adaptive immunity, supporting the potential interest of targeting the sinus epithelium and the microbiome as potential CRS therapies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2023.1046684","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T05:10:55Z","timestamp":1678857055000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Response to intranasal Lactococcus lactis W136 probiotic supplementation in refractory CRS is associated with modulation of non-type 2 inflammation and epithelial regeneration"],"prefix":"10.3389","volume":"4","author":[{"given":"Saud","family":"Al-Romaih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumkaltoum","family":"Harati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra Endam","family":"Mfuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Filali-Mouhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Renteria Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-020-00218-1","article-title":"Adult chronic rhinosinusitis","volume":"6","author":"Bachert","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jaci.2022.02.016","article-title":"Mechanisms and pathogenesis of chronic rhinosinusitis","volume":"149","author":"Kato","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/alr.22691","article-title":"Azithromycin in high-risk, refractory chronic rhinosinusitus after endoscopic sinus surgery and corticosteroid irrigations: a double-blind, randomized, placebo-controlled trial","volume":"11","author":"Maniakas","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaci.2021.11.010","article-title":"The epithelial barrier hypothesis proposes a comprehensive understanding of the origins of allergic and other chronic noncommunicable diseases","volume":"149","author":"Akdis","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jcf.2022.03.002","article-title":"Elexacaftor-tezacaftor-ivacaftor improves sinonasal outcomes in cystic fibrosis","volume":"21","author":"Stapleton","year":"2022","journal-title":"J Cyst Fibros"},{"key":"B7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/alr.21762","article-title":"Effects of a honeybee lactic acid bacterial microbiome on human nasal symptoms, commensals, and biomarkers","volume":"6","author":"M\u00e5rtensson","year":"2016","journal-title":"International Forum of Allergy & Rhinology (IFAR)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/lio2.93","article-title":"Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: a randomized controlled trial","volume":"2","author":"M\u00e5rtensson","year":"2017","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fcimb.2020.00440","article-title":"Intranasal application of Lactococcus Lactis W136 is safe in chronic rhinosinusitis patients with previous sinus surgery","volume":"10","author":"Endam","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Methods"},{"key":"B11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc, B"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/060012","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2019","journal-title":"bioRxiv"},{"key":"B13","doi-asserted-by":"publisher","first-page":"616713","DOI":"10.3389\/fimmu.2021.616713","article-title":"Modulatory effects of probiotics during pathogenic infections with emphasis on immune regulation","volume":"12","author":"Raheem","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaci.2020.08.036","article-title":"A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps","volume":"147","author":"Delemarre","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"155890","DOI":"10.1016\/j.cyto.2022.155890m","article-title":"The IL-1 cytokine family as custodians of barrier immunity","volume":"154","author":"Matarazzo","year":"2022","journal-title":"Cytokine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61341-3","article-title":"Author correction: chronic IL-1\u03b2-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"L945","DOI":"10.1152\/ajplung.00149.2011","article-title":"Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-\u03b1 after injury","volume":"301","author":"Maill\u00e9","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jaci.2020.04.010","article-title":"Epithelial barriers in allergy and asthma","volume":"145","author":"Hellings","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jaci.2018.05.035","article-title":"Staphylococcus aureus impairs sinonasal epithelial repair: effects in patients with chronic rhinosinusitis with nasal polyps and control subjects","volume":"143","author":"Valera","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16147","DOI":"10.1038\/srep16147","article-title":"Lactobacillus rhamnosus GG lysate increases re-epithelialization of keratinocyte scratch assays by promoting migration","volume":"5","author":"Mohammed saeed","year":"2015","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1046684\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T05:10:58Z","timestamp":1678857058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1046684\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":21,"alternative-id":["10.3389\/falgy.2023.1046684"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2023.1046684","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"article-number":"1046684"}}